Concepedia

Author

Harry Towbin

Novartis (Switzerland)

Also Known As

H Towbin, H. TOWBIN, H. Towbin, HARRY TOWBIN, Harry TOWBIN, Harry Towbin

86

Publications

60.5K

Citations

35

H-Index

112

Concepts

All Affiliations

Novartis (Switzerland)University Hospital of BernETH ZurichUniversity of BernFriedrich Miescher Institute
HT

About

Harry Towbin is an author at Novartis (Switzerland) specializing in medicine, immunology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

37

56.5K

2

Natural Sciences

14

14

55.2K

3

Allergy

9

9

522

4

Engineering

3

3

493

5

Health Sciences

3

3

202

Harry Towbin

×

56

Publications

58.5K

Citations

33

H-Index

YearCitations

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Harry Towbin, T. Staehelin, J. Gordon

Proceedings of the National Academy of Sciences

1979

53.8K

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

J M Wood, Guido Bold, Elisabeth Buchdunger,

PubMed

2000

846

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets : procedure and some applications. 1979 [classical article]

Harry Towbin

Biotechnology(Faisalabad)

1992

452

Isotope-Tagged Cross-Linking Reagents. A New Tool in Mass Spectrometric Protein Interaction Analysis

D. R. Müller, Patrick Schindler, Harry Towbin,

Analytical Chemistry

2001

221

The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots.

Peter Nielsen, Keith Manchester, Harry Towbin,

Journal of Biological Chemistry

1982

181

Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes.

Harry Towbin, Günter Rosenfelder, Jörgen Wieslander,

The Journal of Experimental Medicine

1987

171

The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation

Jean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke,

Journal of Pharmacology and Experimental Therapeutics

2009

159

Proteomics-based Target Identification

Harry Towbin, Kenneth W. Bair, James A. DeCaprio,

Journal of Biological Chemistry

2003

144

A Small-Molecule Inhibitor of Lin28

Martina Roos, Ugo Pradère, Richard Patryk Ngondo,

ACS Chemical Biology

2016

142

Characterization of Histone H2A and H2B Variants and Their Post-translational Modifications by Mass Spectrometry

Débora Bonenfant, M. Coulot, Harry Towbin,

Molecular & Cellular Proteomics

2005

139

Page 1